BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 22094224)

  • 21. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
    Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC
    Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.
    Filippi-Chiela EC; Thomé MP; Bueno e Silva MM; Pelegrini AL; Ledur PF; Garicochea B; Zamin LL; Lenz G
    BMC Cancer; 2013 Mar; 13():147. PubMed ID: 23522185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.
    Oliveira KA; Dal-Cim TA; Lopes FG; Nedel CB; Tasca CI
    Purinergic Signal; 2017 Sep; 13(3):305-318. PubMed ID: 28536931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.
    Rocha CR; Kajitani GS; Quinet A; Fortunato RS; Menck CF
    Oncotarget; 2016 Jul; 7(30):48081-48092. PubMed ID: 27344172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
    D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
    Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
    Yin H; Zhou Y; Wen C; Zhou C; Zhang W; Hu X; Wang L; You C; Shao J
    Oncol Rep; 2014 Oct; 32(4):1610-6. PubMed ID: 25050915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
    Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM
    Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
    Kanzawa T; Germano IM; Komata T; Ito H; Kondo Y; Kondo S
    Cell Death Differ; 2004 Apr; 11(4):448-57. PubMed ID: 14713959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells.
    Lin CJ; Lee CC; Shih YL; Lin CH; Wang SH; Chen TH; Shih CM
    PLoS One; 2012; 7(6):e38706. PubMed ID: 22745676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.
    Natsume A; Wakabayashi T; Ishii D; Maruta H; Fujii M; Shimato S; Ito M; Yoshida J
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):653-9. PubMed ID: 17564708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV; Sonabend AM; Nandi S; Khramtsov A; Han Y; Lesniak MS
    Br J Cancer; 2009 Apr; 100(7):1154-64. PubMed ID: 19277041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.
    Conway GE; Casey A; Milosavljevic V; Liu Y; Howe O; Cullen PJ; Curtin JF
    Br J Cancer; 2016 Feb; 114(4):435-43. PubMed ID: 26882067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model.
    Huang TT; Hlavaty J; Ostertag D; Espinoza FL; Martin B; Petznek H; Rodriguez-Aguirre M; Ibañez CE; Kasahara N; Gunzburg W; Gruber HE; Pertschuk D; Jolly DJ; Robbins JM
    Cancer Gene Ther; 2013 Oct; 20(10):544-51. PubMed ID: 23969884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of antiglioma effect with combined temozolomide and interferon-beta.
    Park JA; Joe YA; Kim TG; Hong YK
    Oncol Rep; 2006 Dec; 16(6):1253-60. PubMed ID: 17089046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells
    Chen Z; Zhu G; Sheng C; Lei J; Song S; Zhu J
    Comput Intell Neurosci; 2022; 2022():5266770. PubMed ID: 35800695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
    Momota H; Nerio E; Holland EC
    Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence.
    Berte N; Lokan S; Eich M; Kim E; Kaina B
    Oncotarget; 2016 Oct; 7(41):67235-67250. PubMed ID: 27626497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.